A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
AbbVie
AbbVie
Biomea Fusion Inc.
Hebei Senlang Biotechnology Inc., Ltd.
Taproot Health
Adaptive Biotechnologies
Pack Health
Newave Pharmaceutical Inc
Karyopharm Therapeutics Inc
Notable Labs
AstraZeneca
Medigene AG
Gilead Sciences
Kiadis Pharma
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Novartis
Incuron
Mirror Biologics, Inc.
Otsuka Pharmaceutical Co., Ltd.
4SC AG
Cellerant Therapeutics
INSYS Therapeutics Inc
Texas Oncology Cancer Center
Millennium Pharmaceuticals, Inc.
Accenture